T
Thomas J. Dengler
Researcher at Heidelberg University
Publications - 165
Citations - 7590
Thomas J. Dengler is an academic researcher from Heidelberg University. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 43, co-authored 164 publications receiving 6924 citations. Previous affiliations of Thomas J. Dengler include Yale University & University Hospital Heidelberg.
Papers
More filters
Journal ArticleDOI
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo,Anne I. Dipchand,Randall C. Starling,Allen S. Anderson,Michael Chan,Shashank Desai,Savitri Fedson,Patrick W. Fisher,Gonzalo Gonzales-Stawinski,Luigi Martinelli,David C. McGiffin,Jon Smith,David O. Taylor,Bruno Meiser,Steven A. Webber,David A. Baran,Michael P. Carboni,Thomas J. Dengler,David L. Feldman,Maria Frigerio,Abdallah G. Kfoury,Daniel Kim,Jon A. Kobashigawa,Michael A. Shullo,Josef Stehlik,Jeffrey J. Teuteberg,Patricia A. Uber,Andreas Zuckermann,Sharon A. Hunt,Michael Burch,Geetha Bhat,Charles E. Canter,Richard E. Chinnock,Marisa G. Crespo-Leiro,Reynolds M. Delgado,Fabienne Dobbels,Kathleen L. Grady,W. Kao,Jaqueline Lamour,Gareth Parry,Jignesh Patel,Daniela Pini,Jeffrey A. Towbin,Gene Wolfel,Diego H. Delgado,Howard J. Eisen,Lee R. Goldberg,Jeff Hosenpud,Maryl R. Johnson,Anne Keogh,Clive Lewis,John B. O'Connell,Joseph G. Rogers,Heather J. Ross,Stuart D. Russell,Johan Vanhaecke,Amanda W. Rowe +56 more
TL;DR: Institutional Affiliations Chair Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA Task Force 1 Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Starlings R: University of Chicago, Chicago, Illinois,USA; Chan M: university of Alberta, Edmonton, Alberta, Canada ; Desai S: Inova Fairfax Hospital, Fairfax, Virginia, USA.
Journal Article
Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.
Andreas Papapetropoulos,Guillermo García-Cardeña,Thomas J. Dengler,Maisonpierre Peter C,George D. Yancopoulos,William C. Sessa +5 more
TL;DR: It is shown that Ang-1 dose-dependently stabilizes HUVEC network organization for up to 48 hours and interacts with other angiogenic molecules to stabilize vascular structures by promoting the survival of differentiated ECs.
Journal ArticleDOI
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Christian Erbel,Lili Chen,Florian Bea,Susanne Wangler,S. Celik,Felix Lasitschka,Ying Wang,Dittmar Böckler,Hugo A. Katus,Thomas J. Dengler +9 more
TL;DR: The present data support a pathogenic role of IL-17A in the development of atherosclerosis by way of its widespread proinflammatory and proapoptotic effects on atherogenic cells.
Journal ArticleDOI
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.
Arnt V. Kristen,Thomas J. Dengler,Ute Hegenbart,Stefan Schönland,Hartmut Goldschmidt,Falk-Udo Sack,Frederik Voss,Rüdiger Becker,Hugo A. Katus,Alexander Bauer +9 more
TL;DR: Better predictors of arrhythmia-associated SCD and randomized trials are required to elucidate the impact of ICD placement in high-risk patients with cardiac amyloidosis.
Journal ArticleDOI
Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation
Gábor Szabó,Susanne Bährle,Nicole Stumpf,Karin Sonnenberg,Éva Szabó,Pal Pacher,Tamás Csont,Richard Schulz,Thomas J. Dengler,Lucas Liaudet,Prakash Jagtap,Garry J. Southan,Christian F. Vahl,Siegfried Hagl,Csaba Szabó +14 more
TL;DR: Pharmacological PARP inhibition reduces reperfusion injury after heart transplantation due to prevention of energy depletion and downregulation of adhesion molecules and exerts a beneficial effect against reperfusions-induced graft coronary endothelial dysfunction.